Sky Bear Technical Standards - Home
Search
×
FR

Placeholder headline

This is just a placeholder headline

TEMA 2026 Edition – Online Subscription Only

$

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 15SIH, 2nd Edition: Installation and Handling of Spoolable Reinforced Plastic Line Pipe

$

158

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 754, 4th Edition: Process Safety Performance Indicators for the Refining and Petrochemical Industries

$

393

BUY NOW

Placeholder headline

This is just a placeholder headline

ASME B31.1-2020: Power Piping

$

668

BUY NOW

Placeholder headline

This is just a placeholder headline

ASME B31.1-2022: Power Piping

$

668

BUY NOW

ISO 4424:2023

ISO 4424:2023 Genomics informatics – Data elements and their metadata for describing the tumor mutation burden (TMB) information of clinical massive parallel DNA sequencing

CDN $261.00

SKU: e9ef4ca1edf2 Categories: ,

Description

This document identifies data elements and metadata to represent the information about tumor mutation burden (TMB) when reporting the value for the biomarker using clinical massive parallel DNA sequencing.

This document covers the TMB status and related metadata such as mutation type, sequencing types, and target areas of sequencing from human samples for clinical practice and research.

This document is not intended

     to define experimental protocols or methods for calculating the value of tumor mutation burden,

     for the other biological species, and

     for the Sanger sequencing methods.

Edition

1

Published Date

2023-12-11

Status

PUBLISHED

Pages

20

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

This document identifies data elements and metadata to represent the information about tumor mutation burden (TMB) when reporting the value for the biomarker using clinical massive parallel DNA sequencing.

This document covers the TMB status and related metadata such as mutation type, sequencing types, and target areas of sequencing from human samples for clinical practice and research.

This document is not intended

-     to define experimental protocols or methods for calculating the value of tumor mutation burden,

-     for the other biological species, and

-     for the Sanger sequencing methods.

Previous Editions

Can’t find what you are looking for?

Please contact us at: